Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy-Reference-Cited by-同舟云学术

Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy

Published:2018-04-09 Issue:5 Volume:128 Page:1971-1984
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Zeng Bijun,Middelberg Anton P.J.,Gemiarto Adrian,MacDonald Kelli,Baxter Alan G.^ORCID,Talekar Meghna,Moi Davide,Tullett Kirsteen M.,Caminschi Irina,Lahoud Mireille H.,Mazzieri Roberta,Dolcetti Riccardo^ORCID,Thomas Ranjeny^ORCID

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/96791/files/pdf

Reference61 articles.

1. Vaccines for established cancer: overcoming the challenges posed by immune evasion

2. Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine

3. Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors

4. Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

5. Next-Generation Cancer Vaccine Approaches: Integrating Lessons Learned From Current Successes With Promising Biotechnologic Advances

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effector Functions of Dendritic Cells in Cancer: Role of Cytotoxicity and Growth Inhibition;Frontiers in Bioscience-Landmark;2024-08-20

2. Nanotechnology for Drug Design and Drug Delivery;Nanotechnology in Drug Discovery;2024-07-04

3. Role of Biofunctionalized Nanoparticles in Digestive Cancer Vaccine Development;Pharmaceutics;2024-03-16

4. Recent progress in cancer immunotherapy: Application of nano-therapeutic systems;Journal of Drug Delivery Science and Technology;2024-01

5. Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines;Cancer Research;2023-12-06